Black Rock Inc. Arvinas, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,494,254 shares of ARVN stock, worth $182 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,494,254

Previous 5,354,864 2.6%

Holding current value

$182 Million

Previous $220 Million 2.9%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $5.07 Million - $7.29 Million	139,390 Added 2.6%	5,494,254 $227 Million
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $5.47 Million - $16.3 Million	385,256 Added 7.75%	5,354,864 $220 Million
Q3 2023 Nov 13, 2023	BUY	$19.64 - $28.21 $1.3 Million - $1.87 Million	66,139 Added 1.35%	4,969,608 $97.6 Million
Q2 2023 Aug 11, 2023	BUY	$21.73 - $31.43 $9.3 Million - $13.4 Million	427,871 Added 9.56%	4,903,469 $122 Million
Q1 2023 May 12, 2023	BUY	$26.15 - $37.26 $3.12 Million - $4.45 Million	119,428 Added 2.74%	4,475,598 $122 Million

Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $21.1 Million - $37.2 Million	649,662 Added 17.53%	4,356,170 $149 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.31 Million - $1.82 Million	31,339 Added 0.85%	3,706,508 $165 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $5.4 Million - $11.1 Million	149,910 Added 4.25%	3,675,169 $155 Million
Q1 2022 May 12, 2022	BUY	$60.27 - $81.57 $1.18 Million - $1.59 Million	19,519 Added 0.56%	3,525,259 $237 Million
Q4 2021 Feb 10, 2022	BUY	$65.85 - $96.21 $15.2 Million - $22.2 Million	230,284 Added 7.03%	3,505,740 $288 Million
Q3 2021 Nov 09, 2021	BUY	$73.2 - $107.87 $12.1 Million - $17.8 Million	165,086 Added 5.31%	3,275,456 $269 Million
Q2 2021 Aug 11, 2021	BUY	$60.45 - $84.26 $188 Million - $262 Million	3,110,370 New	3,110,370 $239 Million

Others Institutions Holding ARVN

# of Institutions

234

Shares Held

64.9M

Call Options Held

119K

Put Options Held

94.2K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.76B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account